The meaning of R1 resection after endoscopic removal of gastric, duodenal and rectal neuroendocrine tumors

被引:8
作者
Esposito, Gianluca [1 ]
Dell'Unto, Elisabetta [1 ]
Ligato, Irene [1 ]
Marasco, Matteo [1 ]
Panzuto, Francesco [1 ,2 ]
机构
[1] Sapienza Univ Rome, St andrea Univ Hosp, ENETS Ctr Excellence, Dept Med Surg Sci,Translat Med,Digest Dis Unit, Rome, Italy
[2] Sapienza Univ Rome, St Andrea Univ Hosp, Dept Med Surg Sci & Translat Med, Via Grottarossa 1035, I-00189 Rome, Italy
关键词
endoscopy; neuroendocrine tumors; stomach; rectum; duodenum; tumor progression; residual disease; polypectomy; CARCINOID-TUMORS; MUCOSAL RESECTION; SUBMUCOSAL DISSECTION; TREATMENT OUTCOMES; CLINICAL-OUTCOMES; NON-AMPULLARY; RISK-FACTORS; FOLLOW-UP; MANAGEMENT; EFFICACY;
D O I
10.1080/17474124.2023.2242261
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
IntroductionWell-differentiated gastric, duodenal, and rectal neuroendocrine neoplasms (NETs) are rare diseases usually managed by endoscopic treatment. Although several endoscopic techniques are available, the number of patients with incomplete (R1) resection is significant.Areas coveredThis review focuses on the meaning of incomplete R1 findings after endoscopic resection in type I gastric NETs; nonfunctioning, non-ampullary duodenal NETs; and small rectal NETs. Data were identified by MEDLINE database search without publication date limitation.Expert opinionAn incomplete R1 finding may have no significant impact on a patient's clinical outcome, particularly in small G1 type I gastric NETs, which have an indolent course. A 'stepwise approach,' which uses more advanced endoscopic techniques, or minimally invasive surgery may be justified to achieve complete margin-free resection. This approach must balance the tumor features and the procedure-related risk of complications, particularly in the duodenum, where the role of deep endoscopic resections is limited due to the thin duodenal wall. Gastric and rectal NETs that are incompletely removed after initial resection are more easily amenable to deep endoscopic techniques. However, this might not be necessary for patients with comorbidities, elderly, or both due to the uncertainty of how R1 finding impacts a patient's clinical outcome.
引用
收藏
页码:785 / 793
页数:9
相关论文
共 61 条
  • [31] Endoscopic Resection of Duodenal Carcinoid Tumors A Single-Center Comparison Between Simple Polypectomy and Endoscopic Mucosal Resection
    Mahmud, Nadim
    Tomizawa, Yutaka
    Stashek, Kristen
    Katona, Bryson W.
    Ginsberg, Gregory G.
    Metz, David C.
    [J]. PANCREAS, 2019, 48 (01) : 60 - 65
  • [32] Diagnosis and Management of Rectal Neuroendocrine Tumors (NETs)
    Maione, Francesco
    Chini, Alessia
    Milone, Marco
    Gennarelli, Nicola
    Manigrasso, Michele
    Maione, Rosa
    Cassese, Gianluca
    Pagano, Gianluca
    Tropeano, Francesca Paola
    Luglio, Gaetano
    De Palma, Giovanni Domenico
    [J]. DIAGNOSTICS, 2021, 11 (05)
  • [33] A Multi-institutional Analysis of Duodenal Neuroendocrine Tumors: Tumor Biology Rather than Extent of Resection Dictates Prognosis
    Margonis, Georgios Antonios
    Samaha, Mario
    Kim, Yuhree
    Postlewait, Lauren McLendon
    Kunz, Pamela
    Maithel, Shishir
    Thuy Tran
    Berger, Nickolas
    Gamblin, T. Clark
    Mullen, Matthew G.
    Bauer, Todd W.
    Pawlik, Timothy M.
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2016, 20 (06) : 1098 - 1105
  • [34] Full-thickness resection of neuroendocrine tumors in the rectum
    Meier, Benjamin
    Albrecht, Heinz
    Wiedbrauck, Thomas
    Schmidt, Arthur
    Caca, Karel
    [J]. ENDOSCOPY, 2020, 52 (01) : 68 - 72
  • [35] Type I Gastric Carcinoids: A Prospective Study on Endoscopic Management and Recurrence Rate
    Merola, Elettra
    Sbrozzi-Vanni, Andrea
    Panzuto, Francesco
    D'Ambra, Giancarlo
    Di Giulio, Emilio
    Pilozzi, Emanuela
    Capurso, Gabriele
    Lahner, Edith
    Bordi, Cesare
    Annibale, Bruno
    Delle Fave, Gianfranco
    [J]. NEUROENDOCRINOLOGY, 2012, 95 (03) : 207 - 213
  • [36] Clinicopathological features and outcome of type 3 gastric neuroendocrine tumours
    Min, B. -H.
    Hong, M.
    Lee, J. H.
    Rhee, P. -L.
    Sohn, T. S.
    Kim, S.
    Kim, K. -M.
    Kim, J. J.
    [J]. BRITISH JOURNAL OF SURGERY, 2018, 105 (11) : 1480 - 1486
  • [37] Management Strategy for Small Duodenal Carcinoid Tumors: Does Conservative Management with Close-Follow-Up Represent an Alternative to Endoscopic Treatment?
    Min, Byung-Hoon
    Kim, Eun Ran
    Lee, Jun Haeng
    Kim, Kyoung-Mee
    Min, Yang Won
    Rhee, Poong-Lyul
    Kim, Jae J.
    Rhee, Jong Chul
    [J]. DIGESTION, 2013, 87 (04) : 247 - 253
  • [38] Long-Term Clinical Outcomes of Rectal Neuroendocrine Tumors According to the Pathologic Status After Initial Endoscopic Resection: A KASID Multicenter Study
    Moon, Chang Mo
    Huh, Kyu Chan
    Jung, Sung-Ae
    Park, Dong Il
    Kim, Won Hee
    Jung, Hye Mi
    Koh, Seong-Joon
    Kim, Jin-Oh
    Jung, Yunho
    Kim, Kyeong Ok
    Kim, Jong Wook
    Yang, Dong-Hoon
    Shin, Jeong Eun
    Shin, Sung Jae
    Kim, Eun Soo
    Joo, Young-Eun
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (09) : 1276 - 1285
  • [39] Endoscopic mucosal resection with suction vs. endoscopic submucosal dissection for small rectal neuroendocrine tumors: a meta-analysis
    Pan, Jianmei
    Zhang, Xiaohua
    Shi, Yongjun
    Pei, Qingshan
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2018, 53 (09) : 1139 - 1145
  • [40] European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1-G3
    Panzuto, Francesco
    Ramage, John
    Pritchard, D. Mark
    van Velthuysen, Marie-Louise F.
    Schrader, Joerg
    Begum, Nehara
    Sundin, Anders
    Falconi, Massimo
    O'Toole, Dermot
    [J]. JOURNAL OF NEUROENDOCRINOLOGY, 2023,